Owlstone Medical Establishes Scientific Advisory Board
The company recently appointed Sir Bruce Ponder, FRCP, FMedSci, FRS, to provide unique research perspectives and clinical expertise.
Read MorePosted by Elaine Sanchez Wilson | Jul 11, 2017 | Cancer |
The company recently appointed Sir Bruce Ponder, FRCP, FMedSci, FRS, to provide unique research perspectives and clinical expertise.
Read MorePosted by Elaine Sanchez Wilson | Jul 11, 2017 | Cancer, Lung Cancer |
New single-use aspiration needles are designed to offer improved access, usability, and puncture of difficult-to-access lymph node targets.
Read MorePosted by Elaine Sanchez Wilson | Jun 26, 2017 | Cancer, Lung Cancer, Molecular Diagnostics |
FDA has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing-based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell lung cancer.
Read MorePosted by Elaine Sanchez Wilson | Jun 5, 2017 | Disease States |
A number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read MorePosted by Steve Halasey | Jun 5, 2017 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics, Specimen Collection & Handling |
Blood-based genomic tests are improving treatment decision and start times.
Read More